Lehman Gregg Owen
Known title: DirectorCIK: 0001376620
Associated companies
Transaction History
| INFU | ▼ Sell | Open Market | 25,000 | $228K | 6/16/2023 | View on chart |
| INFU | ▲ Buy | Option Exercise | 25,000 | $215K | 6/16/2023 | View on chart |
| INFU | ▲ Buy | Option Exercise | 25,000 | $118K | 12/2/2022 | View on chart |
| INFU | ▼ Sell | Open Market | 25,000 | $219K | 12/2/2022 | View on chart |
| INFU | ▲ Buy | Option Exercise | 19,743 | $63K | 11/9/2022 | View on chart |
| INFU | ▼ Sell | Open Market | 19,743 | $177K | 11/9/2022 | View on chart |
| INFU | ▲ Buy | Option Exercise | 1,900 | $6K | 9/12/2022 | View on chart |
| INFU | ▼ Sell | Open Market | 1,900 | $15K | 9/12/2022 | View on chart |
| INFU | ▲ Buy | Option Exercise | 4,468 | $14K | 9/9/2022 | View on chart |
| INFU | ▼ Sell | Open Market | 4,468 | $35K | 9/9/2022 | View on chart |
| INFU | ▲ Buy | Option Exercise | 8,889 | $28K | 9/8/2022 | View on chart |
| INFU | ▼ Sell | Open Market | 8,889 | $69K | 9/8/2022 | View on chart |
| INFU | ▲ Buy | Option Exercise | 30,000 | $59K | 6/17/2022 | View on chart |
| INFU | ▼ Sell | Open Market | 30,000 | $265K | 6/17/2022 | View on chart |
| INFU | ▲ Buy | Option Exercise | 10,000 | $20K | 5/18/2022 | View on chart |
| INFU | ▼ Sell | Open Market | 10,000 | $86K | 5/18/2022 | View on chart |
| INFU | ▲ Buy | Option Exercise | 20,000 | $40K | 3/17/2022 | View on chart |
| INFU | ▼ Sell | Open Market | 20,000 | $215K | 3/17/2022 | View on chart |
| INFU | ▲ Buy | Option Exercise | 5,808 | $14K | 12/3/2021 | View on chart |
| INFU | ▼ Sell | Open Market | 5,808 | $93K | 12/3/2021 | View on chart |
| INFU | ▲ Buy | Option Exercise | 255 | $609 | 12/2/2021 | View on chart |
| INFU | ▼ Sell | Open Market | 255 | $4K | 12/2/2021 | View on chart |
| INFU | ▲ Buy | Option Exercise | 2,645 | $6K | 12/1/2021 | View on chart |
| INFU | ▼ Sell | Open Market | 2,645 | $43K | 12/1/2021 | View on chart |
| INFU | ▲ Buy | Option Exercise | 1,292 | $3K | 11/30/2021 | View on chart |
| INFU | ▼ Sell | Open Market | 1,292 | $22K | 11/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
INFU Shares Business Overview, Emphasizes Patient-First Strategy
INFU held a discussion outlining its business model and growth plans, highlighting a patient‑first approach to its services. The company emphasized expanding its product portfolio and improving customer engagement. The talk comes as the stock is near a key support level and shows moderate momentum. Analysts see upside potential, with a target range of $15‑$18.
INFU Shares Business Overview, Emphasizes Patient-First Strategy. INFU held a discussion outlining its business model and growth plans, highlighting a patient‑first approach to its services. The company emphasized expanding its product portfolio and improving customer engagement. The talk comes as the stock is near a key support level and shows moderate momentum. Analysts see upside potential, with a target range of $15‑$18.